XML 38 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders Equity (Tables)
9 Months Ended
Oct. 31, 2020
Stockholders' equity  
Assumptions used to calculate the fair value of the options granted

Stock Options

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

per Share

 

 

Weighted

Average

Remaining

Contractual

Term (in years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding at January 31, 2020

 

 

24,900

 

 

$11.17

 

 

 

9.53

 

 

$

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at October 31, 2020

 

 

24,900

 

 

$11.17

 

 

 

8.78

 

 

$

 

Exercisable at October 31, 2020

 

 

8300

 

 

 

11.17

 

 

 

8.78

 

 

 

 

Schedule of restricted stock units award activity

 

 

Performance-

Based

 

 

Service-

Based

 

 

Total

 

 

Weighted

Average

Grant Date

Fair Value

 

Outstanding at January 31, 2020

 

 

159,241

 

 

 

9,930

 

 

 

169,171

 

 

$11.40

 

Awarded

 

 

90,591

 

 

 

6,326

 

 

 

96,917

 

 

 

16.38

 

Vested

 

 

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

Outstanding at October 31, 2020

 

 

249,832

 

 

 

16,256

 

 

 

266,088

 

 

$13.22

 

Schedule of stock option activity

 

 

Number of shares awarded total

 

 

 

Minimum

 

 

Target

 

 

Maximum

 

Employees

 

 

78,004

 

 

 

120,006

 

 

 

144,009

 

Non-Employee Directors

 

 

27,664

 

 

 

42,560

 

 

 

51,072

 

Total

 

 

105,668

 

 

 

162,566

 

 

 

195,081

 

 

 

 

Value at grant date

 

 

 

Minimum

 

 

Target

 

 

Maximum

 

Employees

 

$943,540

 

 

$1,451,600

 

 

$1,741,920

 

Non-Employee Directors

 

 

338,000

 

 

 

520,000

 

 

 

624,000

 

Total

 

$1,281,540

 

 

$1,971,600

 

 

$2,365,920

 

Schedule of share-based compensation

 

 

Three Months Ended

October 31,

 

 

Nine Months Ended

October 31,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

2017 Plan:

 

 

 

 

 

 

 

 

 

 

 

 

Restricted Stock Program

 

$793

 

 

$(345)

 

$1,143

 

 

$(596)

Stock Options

 

 

15

 

 

 

 

 

 

44

 

 

 

 

Other

 

 

27

 

 

 

 

 

 

58

 

 

 

 

Total stock-based compensation

 

$835

 

 

$(345)

 

$1,245

 

 

$(596)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total income tax benefit (expense) recognized for stock-based compensation arrangement

 

$175

 

 

$(72)

 

$

262

 

 

$(125)
Schedule of nonvested share activity

 

 

Number of shares awarded total

 

 

 

Minimum

 

 

Target

 

 

Maximum

 

 

Cap

 

Employees

 

 

17,834

 

 

 

26,753

 

 

 

35,670

 

 

 

42,805

 

Non-Employee Directors

 

 

7,168

 

 

 

10,752

 

 

 

14,336

 

 

 

17,204

 

Total

 

 

25,002

 

 

 

37,505

 

 

 

50,006

 

 

 

60,009

 

 

 

 

Value at grant date

 

 

 

Minimum

 

 

Target

 

 

Maximum

 

 

Cap

 

Employees

 

$248,800

 

 

$373,200

 

 

$497,600

 

 

$597,120

 

Non-Employee Directors

 

 

100,000

 

 

 

150,000

 

 

 

200,000

 

 

 

240,000

 

Total

 

$348,800

 

 

$523,200

 

 

$697,600

 

 

$837,120